eGenesis is funded by a premier group of investors who believe in our mission.
Our united passion for science drives us.
eGenesis is a gene editing and genome engineering company committed to the development of safe and effective human transplantable organs, tissues and cells to address the global organ crisis.
eGenesis Headquarters 300 Technology Square Suite 301 Cambridge, MA 02139
eGenesis New York Office 7 Times Sq. 43rd Floor New York, NY 10036